Bath & Body Works: Q3 results top guidance, but sales and EPS decline year over year
Q3 2026 sales and adjusted EPS exceeded company guidance, but both declined year over year. Bath & Body Works raised its full-year sales outlook and authorized a new $500 million share repurchase; holiday-season demand is the next test.
Sources (2)
Updated Nov 19, 2026